Epstein-Barr virus immunotherapy (Genocea)￥GEN-007

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameEpstein-Barr virus immunotherapy (Genocea)￥GEN-007
Drug Alias NameGEN-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasmsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenocea Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenocea Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A